ArticleInternational journal of clinical oncology2010

Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan.

Takeru Shiroiwa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.